Interesting UBS have started to follow the SRX story
"UBS believes Sirtex has a good chance of achieving positive trial results, based on medical literature and previously published results. It suggests that the elevation of SIR-Spheres to a first-line therapy could expand its addressable market sixfold."
http://www.theaustralian.com.au/business/companies/wongs-therapy-works-for-sirtex/story-fn91v9q3-1226296392239
If you put the above link in a google search (not the address bar) then click on the story you will be able to read the full story without having to sign up.
Interesting UBS have started to follow the SRX story"UBS...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.5¢ | $1.71K | 9.773K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2327816 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 2095603 | 36 |
View Market Depth
| Last trade - 12.18pm 15/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |